At Media Center
You Can Access Our Press Releases
编者按：2026年，四川大学迎来建校130周年。值此百卅校庆到来之际，四川大学推出【桃李星光】优秀校友系列专访，追寻校友足迹，讲述奋斗故事。作为四川大学杰出校友，海普瑞联合创始人、集团副总裁李坦日前接受了四川大学记者的采访，文章发表在四川大学官方网站。该专访...
（2026年6月14日，中国深圳）6月13日，由上海报业集团指导、界面财联社主办，中国出海企业协作联盟（CEGA）和南华早报支持的“2026中国企业全球影响力对话”在上海成功举办，活动现场正式揭晓了“中国企业全球影响力年度案例”，深圳市海普瑞药业集团股份有限公司（以下简...
(Shenzhen, June 9, 2026) – Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (“Hepalink” or the “Group”) recently announced that its enoxaparin sodium injection, produced by its wholly-owned subsidiary Shenzhen Techdow Pharmaceutical Co.,...
编者按：2026年，四川大学迎来建校130周年。值此百卅校庆到来之际，四川大学推出【桃李星光】优秀校友系列专访，追寻校友足迹，讲述奋斗故事。本文转载自四川大学官网《川大校友李锂：从奋斗者到有缘人》。作为四川大学杰出校友，海普瑞创始人、董事长、集团总裁李锂在专访...
(Shenzhen, May 13, 2026) – Shenzhen Hepalink Pharmaceutical Group Co., Ltd. ("Hepalink") today announced that enoxaparin sodium injection, manufactured by its subsidiary Shenzhen Techdow Pharmaceutical Co., Ltd. ("Techdow"), has received...
(Shenzhen, April 21, 2026) – On April 20, 2026, The International Society for Pharmaceutical Engineering (ISPE) has officially announced the winners of the 2026 Facility of the Year Awards (FOYA) at the ISPE Europe Annual Conference in C...
In clinical anticoagulation therapy, low molecular weight heparins (LMWHs) are almost ubiquitous. They are widely used in various clinical scenarios, including the prevention and treatment of venous thromboembolism, perioperative anticoa...
Official WeChat Account
